Recent progress in protein-protein interaction study for EGFR-targeted therapeutics

Feiner RC, Müller K (2016)
EXPERT REVIEW OF PROTEOMICS 13(9): 817-832.

Download
No fulltext has been uploaded. References only!
Journal Article | Review | Published | English

No fulltext has been uploaded

Author
;
Abstract
Introduction: Epidermal growth factor receptor (EGFR) expression is upregulated in many tumors and its aberrant signaling drives progression of many cancer types. Consequently, EGFR has become a clinically validated target as extracellular tumor marker for antibodies as well as for tyrosine kinase inhibitors. Within the last years, new mechanistic insights were uncovered and, based on clinical experience as well as progress in protein engineering, novel bio-therapeutic approaches were developed and tested.Areas covered: The potential therapeutic targeting arsenal in the fight against cancer now encompasses bispecific or biparatopic antibodies, DARPins, Adnectins, Affibodies, peptides and combinations of these binding molecules with viral- and nano-particles. We review past and recent binding proteins from the literature and include a brief description of the various targeting approaches. Special attention is given to the binding modes with the EGFR.Expert commentary: Clinical data from the three approved anti EGFR antibodies indicate that there is room for improved therapeutic efficacy. Having choices in size, affinity, avidity and the mode of EGFR binding as well as the possibility to combine various effector functions opens the possibility to rationally design more effective therapeutics.
Publishing Year
ISSN
eISSN
PUB-ID

Cite this

Feiner RC, Müller K. Recent progress in protein-protein interaction study for EGFR-targeted therapeutics. EXPERT REVIEW OF PROTEOMICS. 2016;13(9):817-832.
Feiner, R. C., & Müller, K. (2016). Recent progress in protein-protein interaction study for EGFR-targeted therapeutics. EXPERT REVIEW OF PROTEOMICS, 13(9), 817-832.
Feiner, R. C., and Müller, K. (2016). Recent progress in protein-protein interaction study for EGFR-targeted therapeutics. EXPERT REVIEW OF PROTEOMICS 13, 817-832.
Feiner, R.C., & Müller, K., 2016. Recent progress in protein-protein interaction study for EGFR-targeted therapeutics. EXPERT REVIEW OF PROTEOMICS, 13(9), p 817-832.
R.C. Feiner and K. Müller, “Recent progress in protein-protein interaction study for EGFR-targeted therapeutics”, EXPERT REVIEW OF PROTEOMICS, vol. 13, 2016, pp. 817-832.
Feiner, R.C., Müller, K.: Recent progress in protein-protein interaction study for EGFR-targeted therapeutics. EXPERT REVIEW OF PROTEOMICS. 13, 817-832 (2016).
Feiner, Rebecca Christine, and Müller, Kristian. “Recent progress in protein-protein interaction study for EGFR-targeted therapeutics”. EXPERT REVIEW OF PROTEOMICS 13.9 (2016): 817-832.
This data publication is cited in the following publications:
This publication cites the following data publications:

Export

0 Marked Publications

Open Data PUB

Web of Science

View record in Web of Science®

Sources

PMID: 27424502
PubMed | Europe PMC

Search this title in

Google Scholar